Tuberous Sclerosis clinical trials at UCSD
1 in progress, 0 open to eligible people
Showing trials for
Dose-Ranging Efficacy and Safety Study of Topical Rapamycin Cream for Facial Angiofibroma Associated With Tuberous Sclerosis Complex
Sorry, in progress, not accepting new patients
The study aims to compare the safety and efficacy of two different strengths of Rapamycin cream, topical and placebo over 26 weeks in the treatment of facial angiofibroma (FA) associated with Tuberous Sclerosis Complex (TSC).
La Jolla, California and other locations
Last updated: